Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NMR

Fundamental Facts for Nomura Investors

A strong performer from today's morning trading session is Nomura, whose shares rose 2.3% to $8.08 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

The Market May Be Undervaluing Nomura's Earnings and Assets:

Nomura Holdings, Inc. engages in the provision of investment, financing, and related services to individual, institutional, and government clients worldwide. The company belongs to the Finance sector, which has an average price to earnings (P/E) ratio of 15.92 and an average price to book (P/B) ratio of 1.78. In contrast, Nomura has a trailing 12 month P/E ratio of 10.6 and a P/B ratio of 1.03.

When we divideNomura's P/E ratio by its expected five-year EPS growth rate, we obtain a PEG ratio of 0.81, which indicates that the market is undervaluing the company's projected growth (a PEG ratio of 1 indicates a fairly valued company). Your analysis of the stock shouldn't end here. Rather, a good PEG ratio should alert you that it may be worthwhile to take a closer look at the stock.

Overview of Financial Statements:

2019 2020 2021 2022 2023 2024
Revenue (M) $187,390 $202,008 $171,942 $213,782 $513,352 $1,068,662
Interest Income (M) $32,151 $9,582 -$19,000 $13,517 $29,826 $83,603
Operating Margins 45% 9% 18% 27% 46% 44%
Depreciation & Amort. (M) $1,662 $2,296 $1,717 $1,589 $2,479 $2,552
Diluted Shares (M) 3,143 3,180 3,093 3,140 3,063,523,353 3,066
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS